Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Teva Agrees To $420m Securities Settlement For Alleged Price Fixing
Israeli Firm Denies Wrongdoing; Proposed Settlement Requires Final Approval
Jan 19 2022
•
By
Dean Rudge
Teva was charged by the US DoJ in 2020 • Source: Shutterstock: AVN Photo Lab
More from Legal & IP
More from Generics Bulletin